PharmaShots | Incisive News in 3 Shots

Subscribe Now

IL-23 Antagonists

Janssen Amends its Agreement with Protagonist to Develop and Commercialize IL-23 Antagonists

Janssen Amends its Agreement with Protagonist to Develop and Commercialize IL-23 Antagonists

July 29, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us